PSYENCE BIOMEDICAL LTD. (PBM) — Institutional Holders, Q2 2026
27 institutional investment managers reported a PBM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PBM in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +10,119 sh+$246.00
- Ancora AdvisorsNew · +5,000 sh+$122.00
Biggest sellers
- ARISTEIA CAPITAL, L.L.C.Trimmed · -100,000 sh-$2.4K
- Virtu FinancialSold out · -27,853 sh-$677.00
- Harraden Circle InvestmentsTrimmed · -1,000 sh-$24.00
- TORONTO DOMINION BANKTrimmed · -300 sh-$7.00
PBM 13F holders ranked 1–27 of 27
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Parallel Advisors#1 · 178,750 sh | 178,750 | $575.4K | <0.01% | 0.0% |
| 2 | AdvisorShares Investments#2 · 122,184 sh | 122,184 | $373.9K | 0.05% | New |
| 3 | MORGAN STANLEY#3 · 37,804 sh | 37,804 | $115.7K | 0.00% | New |
| 4 | JANE STREET GROUP#4 · 30,431 sh | 30,431 | $93.1K | 0.00% | New |
| 5 | XTX Topco Ltd#5 · 15,094 sh | 15,094 | $46.2K | <0.01% | New |
| 6 | CITADEL ADVISORS#6 · 11,693 sh | 11,693 | $35.8K | 0.00% | New |
| 7 | Harraden Circle Investments#7 · 1,149,000 sh | 1,149,000 | $27.9K | <0.01% | -0.1% |
| 8 | Polar Asset Management Partners#8 · 733,000 sh | 733,000 | $16.6K | <0.01% | 0.0% |
| 9 | MMCAP International SPC#9 · 600,000 sh | 600,000 | $14.6K | <0.01% | 0.0% |
| 10 | TORONTO DOMINION BANK#10 · 503,012 sh | 503,012 | $12.1K | 0.00% | -0.1% |
| 11 | Calamos Advisors#11 · 500,000 sh | 500,000 | $10.5K | 0.00% | 0.0% |
| 12 | Saba Capital Management, L.P.#12 · 297,847 sh | 297,847 | $7.2K | <0.01% | 0.0% |
| 13 | Clear Street Group#13 · 257,202 sh | 257,202 | $6.3K | 0.00% | 0.0% |
| 14 | GOLDMAN SACHS GROUP#14 · 200,117 sh | 200,117 | $4.9K | 0.00% | 0.0% |
| 15 | LMR Partners LLP#15 · 200,000 sh | 200,000 | $4.9K | 0.00% | 0.0% |
| 16 | D. E. Shaw#16 · 175,352 sh | 175,352 | $3.7K | 0.00% | 0.0% |
| 17 | TENOR CAPITAL MANAGEMENT , L.P.#17 · 150,000 sh | 150,000 | $3.6K | <0.01% | 0.0% |
| 18 | WOLVERINE ASSET MANAGEMENT#18 · 147,101 sh | 147,101 | $3.6K | 0.00% | 0.0% |
| 19 | ARISTEIA CAPITAL, L.L.C.#19 · 115,319 sh | 115,319 | $2.6K | 0.00% | -46.4% |
| 20 | LPL Financial#20 · 49,095 sh | 49,095 | $1.2K | 0.00% | 0.0% |
| 21 | Mint Tower Capital Management B.V.#21 · 50,000 sh | 50,000 | $1.0K | <0.01% | 0.0% |
| 22 | Stonehage Fleming Financial Services Ltd#22 · 89 sh | 89 | $272.00 | 0.00% | 0.0% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#23 · 10,119 sh | 10,119 | $212.00 | 0.00% | New |
| 24 | UBS Group AG#24 · 60 sh | 60 | $184.00 | 0.00% | -75.7% |
| 25 | Ancora Advisors#25 · 5,000 sh | 5,000 | $121.00 | 0.00% | New |
| 26 | Caitlin John#26 · 35 sh | 35 | $107.00 | <0.01% | New |
| 27 | SkyView Investment Advisors#27 · 17,500 sh | 17,500 | $0.00 | 0.00% | New |
Funds that sold out of PBM in Q2 2026 (1)
Held PBM at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Virtu Financial27,853 sh | 27,853 | $1.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.